Vanguard Group Inc Miromatrix Medical Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.19 - $1.94 $11,058 - $18,028	9,293 Added 1.43%	658,548 $862,000
Q1 2023 May 15, 2023	BUY	$1.45 - $3.49 $20,445 - $49,209	14,100 Added 2.22%	649,255 $1.09 Million
Q4 2022 Feb 10, 2023	BUY	$2.5 - $4.44 $514,660 - $914,036	205,864 Added 47.95%	635,155 $1.9 Million
Q3 2022 Nov 14, 2022	BUY	$2.27 - $4.86 $582,808 - $1.25 Million	256,744 Added 148.8%	429,291 $1.88 Million
Q2 2022 Aug 12, 2022	BUY	$3.36 - $4.32 $9,008 - $11,581	2,681 Added 1.58%	172,547 $689,000
Q1 2022 May 13, 2022	BUY	$2.03 - $4.73 $31,444 - $73,267	15,490 Added 10.03%	169,866 $673,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $9.4 $686,973 - $1.45 Million	154,376 New	154,376 $724,000

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.